久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Three-fold increase in remdesivir production in India: Mansukh Mandaviya

expresspharmaMay 07, 2021

Tag: Remdesivir , Mansukh Mandaviya , India

The production of remdesivir is being increased at a rapid pace in the country. In just a few days, India has achieved three times the production capacity of the medicine, and will soon be able to meet the growing demand, informed Mansukh Mandaviya, Minister of State for Chemical and Fertilizers via Twitter yesterday.

He also wrote, “In view of the increase in demand, the number of plants producing remdesivir has also gone up from 20 on 12th April, 2021 to 57 on 4th May, 2021.”

Further, the production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021, according to a statement by Ministry of Chemicals and Fertilizers.

Previous:RBI announces on-tap liquidity window of Rs 50,000 cr for healthcare infra, services firms

Next:MoHF&W issues guidelines for COVID-19 vaccine import by private sector

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service